Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2007-4-3
pubmed:abstractText
Surveillance of group A streptococcal (GAS) infections was undertaken as a major component of the European Commission-funded project on severe GAS disease in Europe (strep-EURO). One aim of strep-EURO was to improve the quality of GAS characterization by standardization of methods. An external quality assurance study (EQA) was therefore carried out to evaluate current global performance. Eleven strep-EURO and seven other streptococcal reference centers received a panel of 20 coded GAS isolates for typing. Conventional phenotypic typing (based on cell surface T and M protein antigens and opacity factor [OF] production) and molecular methods (emm gene typing) were used either as single or combined approaches to GAS typing. T typing was performed by 16 centers; 12 centers found one or more of the 20 strains nontypeable (typeability, 89%), and 11 centers reported at least one incorrect result (concordance, 93%). The 10 centers that tested for OF production achieved 96% concordance. Limited availability of antisera resulted in poor typeability values from the four centers that performed phenotypic M typing (41%), three of which also performed anti-OF typing (typeability, 63%); however, concordance was high for both M (100%) and anti-OF (94%) typing. In contrast, the 15 centers that performed emm gene sequencing achieved excellent typeability (97%) and concordance (98%), although comparison of the performance between centers yielded typeability rates from 65 to 100% and concordance values from 83 to 100%. With the rapid expansion and use of molecular genotypic methods to characterize GAS, continuation of EQA is essential in order to achieve international standardization and comparison of type distributions.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17267628-10221877, http://linkedlifedata.com/resource/pubmed/commentcorrection/17267628-10832648, http://linkedlifedata.com/resource/pubmed/commentcorrection/17267628-10885988, http://linkedlifedata.com/resource/pubmed/commentcorrection/17267628-11254602, http://linkedlifedata.com/resource/pubmed/commentcorrection/17267628-11731942, http://linkedlifedata.com/resource/pubmed/commentcorrection/17267628-12115092, http://linkedlifedata.com/resource/pubmed/commentcorrection/17267628-12748273, http://linkedlifedata.com/resource/pubmed/commentcorrection/17267628-14461914, http://linkedlifedata.com/resource/pubmed/commentcorrection/17267628-14532198, http://linkedlifedata.com/resource/pubmed/commentcorrection/17267628-15189292, http://linkedlifedata.com/resource/pubmed/commentcorrection/17267628-15304473, http://linkedlifedata.com/resource/pubmed/commentcorrection/17267628-15524268, http://linkedlifedata.com/resource/pubmed/commentcorrection/17267628-16434707, http://linkedlifedata.com/resource/pubmed/commentcorrection/17267628-1784271, http://linkedlifedata.com/resource/pubmed/commentcorrection/17267628-8039659, http://linkedlifedata.com/resource/pubmed/commentcorrection/17267628-8170398, http://linkedlifedata.com/resource/pubmed/commentcorrection/17267628-8815115, http://linkedlifedata.com/resource/pubmed/commentcorrection/17267628-9316938
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0095-1137
pubmed:author
pubmed:issnType
Print
pubmed:volume
45
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1175-9
pubmed:dateRevised
2010-9-16
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
International quality assurance study for characterization of Streptococcus pyogenes.
pubmed:affiliation
Respiratory and Systemic Infection Laboratory, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5HT, United Kingdom. shona.neal@hpa.org.uk
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study